With Marta Arnaldi and Karen Thornber Karen Thornber is Harry Tuchman Levin Professor in Literature and Professor of East Asian Languages and Civilizations at Harvard University. She is the author of multiple publications, including three monographs that have shaped and transformed the fields of world literature, global literature, environmental humanities, and medical humanities. Professor Thornber’s latest volume, entitled Global Healing: Literature, Advocacy, Care (BrillContinue reading “‘Global Healing: Towards a World Policy of Care’ – 16 June 2020”
With Marta Arnaldi and Charles Forsdick Charles Forsdick is the James Barrow Professor of French at the University of Liverpool. Since 2012, he has been AHRC Theme Leadership Fellow for ‘Translating Cultures’. He has published widely on travel writing, colonial history, postcolonial literature, comics, penal culture, and the afterlives of slavery. Professor Forsdick is a member of the AcademyContinue reading “‘Translating Cultures in an Age of Confinement’ – 28 May 2020”
With Marta Arnaldi and Nicola Gardini Nicola Gardini is Professor of Italian and Comparative Literature at Keble College, University of Oxford, a painter, and a writer. He has published collections of poetry, novels, essays, literary monographs, memoirs, and translations. He is the recipient of several literary awards, including the prestigious Viareggio Prize for his novel LeContinue reading “‘Translating Illness: The Case of COVID-19’ – 14 May 2020”
In 2018, a so-called crisis developed in the Cochrane network of systematic reviewers. It was widely depicted in terms of two competing narratives – [a] “bad behaviour” by one individual and [b] scientific and moral decline within Cochrane. This presentation will report the attempt of an interdisciplinary group of scholars (from medicine, sociology, critical management studiesContinue reading “‘ “The Crucifixion of Brother Peter”: Moral Claims and Religious Imagery in Two Competing Narratives about the Cochrane Collaboration’ – 17 February 2020”
The discovery of “pioneer medicines” (i.e. those acting via novel molecular targets) has proven to be an immensely complex, long term, expensive and high risk endeavour. Despite formidable investments by the pharmaceutical industry and public/ charitable funders, over the past few decades in both infrastructure and technology, the success rates have remained low. During his presentation,Continue reading “‘We are not good at translating lab science into new medicines for patients’ – 20 January 2020”
MML Research Day, University of Oxford
Can we write creatively in a foreign tongue? How to write (about) the ill body?
The Pathological Body: European Literary and Cultural Perspectives’, IMLR, London, 3 October 2019 [2:11:38–2:29:55]